# A Phase 2 Trial of Rituximab and Corticosteroid Therapy for Newly Diagnosed Chronic Graft Versus Host Disease

> **NCT00350545** · NA · COMPLETED · sponsor: **Stanford University** · enrollment: 37 (actual)

## Conditions studied

- Graft vs Host Disease

## Interventions

- **DRUG:** Rituximab
- **DRUG:** Prednisone
- **DRUG:** Cyclosporine A
- **DRUG:** tacrolimus

## Key facts

- **NCT ID:** NCT00350545
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-08
- **Primary completion:** 2012-05
- **Final completion:** 2014-10
- **Target enrollment:** 37 (ACTUAL)
- **Last updated:** 2017-11-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00350545

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00350545, "A Phase 2 Trial of Rituximab and Corticosteroid Therapy for Newly Diagnosed Chronic Graft Versus Host Disease". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00350545. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*